[Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid].

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

• Publication date

  2007-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1248/YAKUSHI.127.1549PMID 17917417
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid

  2007cited by this paper
• Uptake Pathways and Subsequent Intracellular Trafficking in Nonviral Gene Delivery

  2006cited by this paper
• High Density of Octaarginine Stimulates Macropinocytosis Leading to Efficient Intracellular Trafficking for Gene Expression*

  2006cited by this paper
• Toxicity of cationic lipids and cationic polymers in gene delivery.

  2006cited by this paper
• Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo.

  2005cited by this paper
• Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method.

  2004cited by this paper
• Pharmaco attributes of dioleoylphosphatidylethanolamine/cholesterylhemisuccinate liposomes containing different types of cleavable lipopolymers.

  2004cited by this paper
• Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids.

  2003cited by this paper
• Second Child in French Trial Is Found to Have Leukemia

  2003cited by this paper
• Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations

  2002cited by this paper
• Determination of protease cleavage site motifs using mixture-based oriented peptide libraries

  2001cited by this paper
• Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG--diortho ester--lipid conjugate.

  2001cited by this paper
• Stearylated arginine-rich peptides: a new class of transfection systems.

  2001cited by this paper
• Virus treatment questioned after gene therapy death

  1999cited by this paper
• New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine.

  1999cited by this paper
• Poly(ethylene glycol)-lipid conjugates promote bilayer formation in mixtures of non-bilayer-forming lipids.

  1996cited by this paper
• Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes

  1990cited by this paper
• A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

  1986cited by this paper

• Enhanced in vivo Stability and Antitumor Efficacy of PEGylated Liposomes of Paclitaxel Palmitate Prodrug

  2024cites this paper
• Self-assembled redox-responsive BRD4 siRNA nanoparticles: fomulation and its in vitro delivery in gastric cancer cells

  2024cites this paper
• Cell-Penetrating and Targeted Peptides Delivery Systems as Potential Pharmaceutical Carriers for Enhanced Delivery across the Blood–Brain Barrier (BBB)

  2023cites this paper
• Rationale and Application of PEGylated Lipid-Based System for Advanced Target Delivery of siRNA

  2021cites this paper
• Recent Advances in Nanoparticle-Based Cancer Treatment: A Review

  2021cites this paper
• pH-sensitive PEGylated liposomal silybin: Synthesis, in vitro and in vivo anti-tumor evaluation.

  2021cites this paper
• Nanocarriers-loaded with natural actives as newer therapeutic interventions for treatment of hepatocellular carcinoma

  2020influential citation
• Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers.

  2020cites this paper
• The role of high‐density lipoproteins in antitumor drug delivery

  2019cites this paper
• An efficient PEGylated gene delivery system with improved targeting: Synergism between octaarginine and a fusogenic peptide.

  2018cites this paper
• Lipid nanoparticle-based co-delivery of epirubicin and BCL-2 siRNA for enhanced intracellular drug release and reversing multidrug resistance

  2018cites this paper
• Redox sensitive PEG controlled octaarginine and targeting peptide co-modified nanostructured lipid carriers for enhanced tumour penetrating and targeting in vitro and in vivo

  2018cites this paper
• Enhanced nanoparticle delivery exploiting tumour-responsive formulations

  2018cites this paper
• Comparison of the pharmacological and biological properties of HPMA copolymer‐pirarubicin conjugates: A single‐chain copolymer conjugate and its biodegradable tandem‐diblock copolymer conjugate

  2017cites this paper
• Effect of PEGylation on Ligand-Targeted Magnetoliposomes: A Missed Goal

  2017cites this paper
• Cellular environment-responsive nanomaterials for use in gene and siRNA delivery: molecular design for biomembrane destabilization and intracellular collapse

  2016cites this paper
• Novel prodrug-like fusion toxin with protease-sensitive bioorthogonal PEGylation for tumor targeting.

  2014cites this paper
• Assessment of PEG on polymeric particles surface, a key step in drug carrier translation.

  2014cites this paper
• Tumor-Targeted Nanoparticles: State-of-the-Art and Remaining Challenges

  2013cites this paper
• NANOPARTICLES: STATE-OF-THE- ART AND REMAINING CHALLENGES

  2013cites this paper
• Enzyme-triggered PEGylated pDNA-nanoparticles for controlled release of pDNA in tumors.

  2013cites this paper
• [Development of an efficient short interference RNA (siRNA) delivery system with a new pH-sensitive cationic lipid].

  2012cites this paper
• Designing switchable nanosystems for medical application.

  2012cites this paper
• Invading target cells: multifunctional polymer conjugates as therapeutic nucleic acid carriers

  2011cites this paper
• Enzyme-triggered nanomedicine: Drug release strategies in cancer therapy (Invited Review)

  2010cites this paper
• Nanoparticles for human liver-specific drug and gene delivery systems: in vitro and in vivo advances

  2009influential citation
• der Fakultät für Chemie und Pharmazie der

  2008cites this paper
• Development of a Novel Systemic Gene Delivery System for Cancer Therapy with a Tumor‐Specific Cleavable PEG‐Lipid

  2008cites this paper
• Advances in non-viral gene delivery: using multifunctional envelope-type nano-device

  2008cites this paper
• Non-viral gene delivery: from the needle to the nucleus

  2007cites this paper
• Cell and Tissue Targeting of Nucleic Acids for Cancer Gene Therapy

  2007cites this paper